The role of stromal tumor infiltrating lymphocytes (sTILs) as a predictive biomarker for carboplatin-based neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC).

Sharon Glynn

The role of stromal tumor infiltrating lymphocytes (sTILs) as a predictive biomarker for carboplatin-based neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC).

Pathology

Research output: Chapter in Book or Conference Publication/Proceeding › Conference Publication › peer-review

Original language	English (Ireland)
Title of host publication	Annual Meeting of the American Society of Clinical Oncology
Place of Publication	USA
Publication status	Published - 1 Jun 2019

Authors (Note for portal: view the doc link for the full list of authors)

Authors
Walsh, EM,O'Loughlin, M,Shalaby, A,Webber, M,Kerin, MJ,Glynn, SA,Callagy, G,Keane, MM

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@inproceedings{f0c341333071423e8badf452f15d2ae1,

title = "The role of stromal tumor infiltrating lymphocytes (sTILs) as a predictive biomarker for carboplatin-based neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC).",

author = "Sharon Glynn",

year = "2019",

month = jun,

day = "1",

language = "English (Ireland)",

booktitle = "Annual Meeting of the American Society of Clinical Oncology",

}

The role of stromal tumor infiltrating lymphocytes (sTILs) as a predictive biomarker for carboplatin-based neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC). / Glynn, Sharon.
Annual Meeting of the American Society of Clinical Oncology . USA, 2019.

Research output: Chapter in Book or Conference Publication/Proceeding › Conference Publication › peer-review